BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19136769)

  • 1. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
    Barakzai MA; Pervez S
    Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprofile of Hodgkin's lymphoma in India.
    Patkar N; Mehta J; Kulkarni B; Pande R; Advani S; Borges A
    Indian J Cancer; 2008; 45(2):59-63. PubMed ID: 18626150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.
    García-Cosío M; Santón A; Martín P; Camarasa N; Montalbán C; García JF; Bellas C
    Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
    Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
    Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
    Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
    Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical Hodgkin's disease. Clinical impact of the immunophenotype.
    von Wasielewski R; Mengel M; Fischer R; Hansmann ML; Hübner K; Franklin J; Tesch H; Paulus U; Werner M; Diehl V; Georgii A
    Am J Pathol; 1997 Oct; 151(4):1123-30. PubMed ID: 9327746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].
    Zhou X; Zhao T; Qi Z; Liu G; Zhu M
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1532-5. PubMed ID: 12609061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of Hodgkin's disease in Kampala, Uganda.
    Tumwine LK
    East Afr Med J; 2004 Aug; 81(8):384-7. PubMed ID: 15622930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow involvement in T-cell-rich B-cell lymphoma.
    Skinnider BF; Connors JM; Gascoyne RD
    Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's lymphoma. An immunohistochemical profile in northern Iraq.
    Fadhil MS; Al-Nueimy WM; Lazim AF
    Saudi Med J; 2014 May; 35(5):448-53. PubMed ID: 24825804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
    Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
    Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sinusoidal large cell lymphoma with expression of CD30, CD15, and multiple B-cell antigens: a classical Hodgkin lymphoma with sinusoidal infiltrating pattern or a sinusoidal CD30 positive large B-cell lymphoma with CD15?
    Wang E; Foo WC; Huang Q
    Leuk Lymphoma; 2010 Jun; 51(6):1148-51. PubMed ID: 20443679
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
    Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
    Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
    Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
    Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
    Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
    Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
    Carbonnelle A; Delarue R; Canioni D; Brousse N
    Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.